非生物型人工肝治疗肝衰竭的研究进展  

Research progress of non-biological artificial liver support system therapy for paitents with liver failure

作　　者：马元吉[1] 杜凌遥 白浪[1] 唐红[1] Ma Yuanji;Du Lingyao;Bai Lang;Tang Hong(Center of Infectious Diseases,West China Hospital of Sichuan University,Chengdu 610041,China)

机构地区：[1]四川大学华西医院感染性疾病中心,成都610041

出　　处：《中华肝脏病杂志》2023年第9期1004-1008,共5页Chinese Journal of Hepatology

基　　金：国家重大科技专项课题(2018ZX10715-003);四川大学华西医院学科卓越发展1·3·5工程项目(ZYGD20009)。

摘　　要：肝衰竭病情进展快,病死率高。非生物型人工肝治疗是肝衰竭的重要治疗手段之一。非生物型人工肝治疗的基本技术有血浆置换、血浆吸附和连续性肾脏替代治疗。现结合国内外有关人工肝治疗基本技术的研究进展探讨人工肝治疗肝衰竭的效果、基本技术的选择、治疗时机与可能受益的患者、存在的问题等,希望为临床合理使用人工肝治疗提供参考。Liver failure progresses quickly with high mortality.Non-biological artificial liver support system therapy is one of the important treatments for patients with liver failure.The basic techniques of non-biological artificial liver support system therapy include plasma exchange,plasma adsorption and continuous renal replacement therapy.In this paper,the effect and choice of these basic techniques,the treatment timing,the possible patients who may benefit,and the existing problems are summarized and discussed.We hope to provide a reference for the rational use of non-biological artificial liver support system therapy in clinical practice.

关 键 词：肝衰竭 治疗 预后 非生物型人工肝 

分 类 号：R575.3[医药卫生—消化系统]